These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17936890)

  • 1. IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission.
    Ryan JG; de Koning HD; Beck LA; Booty MG; Kastner DL; Simon A
    J Allergy Clin Immunol; 2008 Jan; 121(1):260-2. PubMed ID: 17936890
    [No Abstract]   [Full Text] [Related]  

  • 2. Remission of Schnitzler syndrome after treatment with anakinra.
    Frischmeyer-Guerrerio PA; Rachamalla R; Saini SS
    Ann Allergy Asthma Immunol; 2008 Jun; 100(6):617-9. PubMed ID: 18592830
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful anakinra therapy in 2 patients with Schnitzler syndrome.
    Szturz P; Adam Z; Hájek R; Mayer J
    Onkologie; 2011; 34(5):265-8. PubMed ID: 21577034
    [No Abstract]   [Full Text] [Related]  

  • 4. [Schnitzler syndrome is a diagnostic challenge].
    Duhn PH; Thomsen SF; Nordin H
    Ugeskr Laeger; 2015 Jul; 177(30):. PubMed ID: 26240044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Schnitzler's syndrome with anakinra: report of three cases and review of the literature.
    Gran JT; Midtvedt Ø; Haug S; Aukrust P
    Scand J Rheumatol; 2011 Jan; 40(1):74-9. PubMed ID: 20936987
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of Schnitzler's syndrome with anakinra.
    Gilson M; Abad S; Larroche C; Dhote R
    Clin Exp Rheumatol; 2007; 25(6):931. PubMed ID: 18173934
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome.
    de Koning HD; Schalkwijk J; van der Meer JW; Simon A
    J Allergy Clin Immunol; 2011 Dec; 128(6):1352-4. PubMed ID: 21704363
    [No Abstract]   [Full Text] [Related]  

  • 8. [Schnitzler syndrome: A dramatic improvement with anakinra].
    Billey T; Beldjerd M; Popa L; Lassoued S
    Presse Med; 2010 Dec; 39(12):1338-9. PubMed ID: 20832239
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of the B-cell compartment in a patient with Schnitzler syndrome.
    Sedivá A; Poloučková A; Podrazil M; Froňková E; Kalina T
    Scand J Rheumatol; 2011 Mar; 40(2):158-60. PubMed ID: 20874520
    [No Abstract]   [Full Text] [Related]  

  • 10. Schnitzler syndrome: response to anakinra in two cases and a review of the literature.
    Schuster C; Kränke B; Aberer E; Arbab E; Sturm G; Aberer W
    Int J Dermatol; 2009 Nov; 48(11):1190-4. PubMed ID: 20064173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Schnitzler syndrome--unknown, rare but treatable].
    Lazarevic V; Markuszewska A; Stenberg B; Häggroth J
    Lakartidningen; 2008 Nov 12-18; 105(46):3348-51. PubMed ID: 19062627
    [No Abstract]   [Full Text] [Related]  

  • 12. Schnitzler Syndrome With Response to Anakinra Monotherapy: 7 Years of Follow-up.
    Hidalgo-García Y; García-Fernández E; Palacio-Aller L; Gonzalvo P
    Actas Dermosifiliogr; 2017 Dec; 108(10):956-958. PubMed ID: 28728792
    [No Abstract]   [Full Text] [Related]  

  • 13. Intracostal neuralgia as a previously undescribed symptom of Schnitzler's syndrome.
    Lee KY; Grattan CE
    Br J Dermatol; 2012 Dec; 167(6):1392-3. PubMed ID: 22591057
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of interleukin 1 receptor antagonist (anakinra) on a refractory case of Schnitzler's syndrome.
    Kluger N; Rivière S; Guillot B; Bessis D
    Acta Derm Venereol; 2008; 88(3):287-8. PubMed ID: 18480937
    [No Abstract]   [Full Text] [Related]  

  • 15. Delayed development of the IgM paraprotein in Schnitzler's syndrome.
    Mulla E; Neame R
    Scand J Rheumatol; 2015; 44(6):521-2. PubMed ID: 26395927
    [No Abstract]   [Full Text] [Related]  

  • 16. [A woman with recurrent urticaria, joint pain and fever].
    Gran JT; Midtvedt Ø; Haug S
    Tidsskr Nor Laegeforen; 2011 Jan; 131(2):135-6. PubMed ID: 21267032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermal interleukin-1 expression and effective and long-lasting therapy with interleukin-1 receptor antagonist anakinra in Schnitzler syndrome.
    Volz T; Wölbing F; Fischer J; Braun M; Maggoschitz I; Schaller M; Berneburg M; Biedermann T
    Acta Derm Venereol; 2012 Jul; 92(4):393-4. PubMed ID: 22334118
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of 2-year treatment of Schnitzler syndrome (urticarial exanthema, monoclonal IgM gammopathy and osteolytic-osteosclerotic skeletal changes) using Anakinra (Kineret)].
    Adam Z; Krejcí M; Pour L; Hájek R
    Vnitr Lek; 2009 Dec; 55(12):1196-7. PubMed ID: 20070037
    [No Abstract]   [Full Text] [Related]  

  • 19. [Schnitzler's syndrome: a case report and literature review of the response to treatment with anakinra].
    Benítez Gutiérrez L; Mellor Pita S; Tutor de Ureta P; Yebra Bango M
    Med Clin (Barc); 2013 May; 140(9):427-8. PubMed ID: 23177777
    [No Abstract]   [Full Text] [Related]  

  • 20. Occurrence of Rheumatoid Arthritis in a Patient Treated with Anakinra for Schnitzler Syndrome: A Case Report.
    Margerin F; Gottenberg JE; Lipsker D
    J Rheumatol; 2016 Jul; 43(7):1447. PubMed ID: 27371651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.